I
t is no surprise that there is increasing attention on compromised maternal mental health given the accumulating evidence on its prevalence and also the meta-analyses regarding the effects of these difficulties on the offspring. 1 A review by Lang et al. is a fruitful starting point from which to focus on the importance of the pre-conception period for improving health outcomes. 2 It has become increasingly clear over decades that many factors, including alcohol, nicotine and substance use in pregnancy, chronic stress and depression, and medications, particularly mood stabilisers such as sodium valproate and carbamazepine, can contribute to deleterious outcomes including foetal abnormalities, small for weight babies, prematurity, and developmental difficulties. It is really no surprise that many of these issues cannot suddenly be changed the instant that a woman conceives and of course by the time she knows she is pregnant, damage may already be done. Enlarging the focus to include pre-conception optimisation of a woman's health appears wise, although not necessarily always fruitful as approximately 50% of pregnancies in Australia are still estimated to be unplanned. General health messages at a public health level aimed at all women of child-bearing age do make sense, and in the perinatal and infant mental health (PIMH) arena, specific information coming to light heightens the need for psychiatric awareness of pre-conception counselling. The National Register for Antipsychotic Medication in Pregnancy (NRAMP), led by Professor Jayashri Kulkarni for 20 years, is revealing that the most adverse effects for women taking antipsychotic medications in pregnancy and their infants are associated with preconception weight gain compared, for instance, with teratogenicity (C. Breadon, personal communication, 2018). Thus, advising all women of child-bearing age on healthy diet, the benefits of exercise, and regular monitoring of weight as well as motivational interviewing regarding substance use are vital strategies linking physical and mental health and longer-term outcomes. These concerns may also guide antipsychotic choice. As the health of the gut microbiome and its link to mental health are further elaborated with prenatal studies now providing more evidence of maternal and infant effects, 3 the Cartesian mind-body duality is further challenged, and our job is to focus on the whole spectrum from pre-conception through childhood on one axis and physical as well as mental health on another.
Moving from preventive measures to therapeutic, a plethora of meta-analyses are helping practitioners to find treatment choices as the volume of published material surges. In their overview of management of many of the higher-prevalence PIMH conditions, Nilni et al. can assure clinicians that cognitive-behaviour therapy, interpersonal psychotherapy and some alternative interventions such as exercise (another link to the mind-body theme) work in high income majority women. 4 Many of these treatments also improve parenting and/or mother/ infant relationships. 5 A meta-analysis focusing on the benefits of family treatment finds good evidence for including other family members and highlights the increasing recognition of including and helping fathers. 6 SMS4Dads is another intervention aimed more directly at helping fathers with the transition to parenthood and with their mental health. 7 Delivered across smartphones and therefore easily and economically accessible, men are educated about fatherhood, partnership and mental health, with positive results. Its ease of use and low cost are seeing its wider adoption.
Expanding the focus on access and cost more generally, Galbally et al.'s 8 concluding remarks on the absence of mother-baby units (MBU) for the expert inpatient care of postnatal mentally ill mothers through much of Australia are echoed by the Royal Australian and New Zealand College of Psychiatry Section of Perinatal and Infant Psychiatry (SPIP), which is strongly advocating better access to these facilities throughout Australia and New Zealand. In the United Kingdom, this 'post-code lottery' for accessing care was identified and provided the impetus for a highly successful advocacy campaign by joint teams of professionals and those with livedexperience, leading to an enormous increase in funding for PIMH. We can do the same here. In primary and secondary care levels in Australia, the National Perinatal Depression Initiative (NPDI) operated from 2009 to 2015. The aims of the NPDI were to increase awareness of and screening for the high prevalence PIMH conditions, (perinatal depression and anxiety) and provide pathways to care. NPDI funding for specialised pathways for care ceased, despite more women now being identified as requiring treatment, causing new pressures to find cost-effective pathways for care. A review by Camacho and Shield describes the difficulties of identifying such pathways but do find two different approaches worthy of consideration. 9 A trial in the United Kingdom showed the benefits of educating health visitors to identify and treat perinatal mental illness. In a very different approach from the United States, hypothetical modelling identifies the potential benefits of engaging general practitioners as the primary source for identifying and treating perinatal women with backup care from psychiatrists. In Australia, item 291 has been aimed at just such a system but often falls short. In South Australia, it has been difficult to maintain a sufficient roster of psychiatrists through a centralised referral point, GPPASA, with patients sometimes waiting months even for a one-off assessment. Perhaps vigorous debate will identify whether the unmet need is the responsibility of State-based services or Commonwealth via Medicare and primary health networks as these two parallel systems do not always mesh well.
Finally, the focus thus far has been mainly on the socalled high prevalence conditions, and it is pleasing to see recently an increasing awareness of perinatal borderline personality disorder (BPD). So little research has been done in this area, it may indeed have significantly higher prevalence than currently identified. As services such as Project Air in New South Wales and Spectrum in Victoria expand their psychoeducation, teaching and clinical services generally for BPD, the summarised effects on infants highlight the urgency of the task to further develop treatment approaches for perinatal BPD. 10 While the focus has traditionally been on the impact of organic factors, such as hypothetical protective effects of pregnancy, it is clear that psychosocial factors such as supportive relationships, and secure finance, accommodation, and health care, can be equally important to the mental wellbeing of mothers and their children.
In April 2019, Australasian Psychiatry podcast Professor Phillip Boyce, Professor of Psychiatry at Sydney University speaks about the unique opportunities involved in the practice of perinatal psychiatry, as well as the barriers to research. The interview covers articles in the April issue which: advocate for increased numbers of Australian mother-baby units; demonstrate that pregnant women do not receive enough information about psychotropic medications; and reveal that as many as 50% of potentially fertile women on sodium valproate have not been made aware of potential teratogenic and neurodevelopmental side effects.
